+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hydrogen Bromide - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2027-2032)

  • PDF Icon

    Report

  • 120 Pages
  • October 2026
  • Region: Global
  • Mordor Intelligence
  • ID: 6292993
The hydrogen bromide market size was valued at USD 3.29 billion in 2026 and is estimated to grow from USD 3.48 billion in 2027 to reach USD 4.55 billion by 2032, at a CAGR of 5.54% during the forecast period (2027-2032). This report is Segmented by Product Form (Anhydrous Hydrogen Bromide, Aqueous Hydrogen Bromide, and Others), Application (Semiconductor Etching, Pharmaceuticals, Agrochemicals, Chemical Synthesis and Catalysis, Oil and Gas, and Others), and Geography (Asia-Pacific, North America, Europe, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Hydrogen Bromide Market Trends and Insights

Semiconductor Advanced-Node Etch Demand

Semiconductor fabrication represented 62% of global HBr consumption, and its demand depends more on node migration than on total wafer output. The hydrogen bromide market benefits when foundries move to 3 nm and 2 nm processes because each node requires more etch steps, tighter control of gate structures, and stable process chemistry. Per-wafer consumption rises by an estimated 15-20% with each node generation as selectivity requirements increase and wafer recipes become more demanding. HBr supports bromide-based passivation that protects sidewalls in polysilicon gate etching at sub-5 nm dimensions, where precision is essential to preserve intended feature shapes. Fabs require 5N or higher purity grades, which limits the number of suppliers that can meet qualification requirements and maintain consistent material quality. Samsung, SK hynix, TSMC, and Micron together accounted for more than half of semiconductor-grade consumption, supporting multi-year supply contracts and recurring demand for qualified producers.

Pharmaceutical API and Salt-Formation Demand

Hydrogen bromide is used as a bromination agent, acid catalyst, and salt-forming reagent for pharmaceutical intermediates. Demand spans central nervous system drugs, antihistamines, antiviral compounds, and oncology intermediates, linking it to several distinct drug-development and generic manufacturing programs. Continuous-flow chemistry can lower HBr use per kilogram of active pharmaceutical ingredient, but more complex brominated small-molecule pipelines can offset those efficiency gains in total output. In 2025, India's pharmaceutical intermediate sector used 35-45% of the domestic HBr supply for pharmaceutical applications. Buyers increasingly value documented material, reliable batch records, and dependable chain-of-custody controls, which can support premium-grade contracts over spot purchases. Requirements under U.S. Current Good Manufacturing Practice (GMP) rules and European GMP guidance favor suppliers with established documentation and quality systems. This segment of the hydrogen bromide market, therefore, depends on pharmaceutical output, regulatory compliance, and the ability to provide consistently qualified material.

Hazardous Handling and Compliance Costs

Hydrogen bromide is classified as a Class 2.3 toxic gas under transport regulations, requiring users to maintain corrosion-resistant equipment, gas detection systems, trained personnel, and high-specification ventilation. Ultra-pure material may require Hastelloy rather than stainless steel cylinders, increasing storage and delivery costs. Facilities covered by OSHA's Process Safety Management standard are subject to extensive operational controls for highly hazardous chemicals. Compliance costs exceeded 10% of end-user operating expenditure, and the 2025 penalty schedule allowed fines of up to USD 165,514 for willful violations. Transport requirements can add 2-4 weeks to lead times, complicating just-in-time supply to semiconductor sites and making inventory planning more critical. Customers in Southeast Asia and South America may face additional constraints due to less developed hazardous-materials logistics infrastructure. Encapsulated or on-site-generated alternatives can reduce bulk-storage risk, but their higher unit costs limit broad adoption.

Other drivers and restraints analyzed in the report include:
  • High-Purity HBr Demand from Fab Localization
  • Hydrogen-Bromine Flow-Battery Pilots
  • Substitution by Alternative Etch Chemistries

Segment Analysis

Anhydrous hydrogen bromide held 65.13% of the hydrogen bromide market share in 2026 and is projected to expand at a 6.13% CAGR through 2032. Its position reflects the requirement for dry-process etching gas in semiconductor manufacturing, where aqueous formulations cannot deliver moisture-free plasma chemistry. Migration to 3 nm and smaller nodes, along with additional etch steps in advanced NAND and DRAM, supports continued demand. Leading fabs require very low trace-metal impurities, with critical gate etch steps at sub-5 nm sites requiring 6N purity.

Aqueous hydrogen bromide, also known as hydrobromic acid, is used in pharmaceutical bromination, agrochemical synthesis, oil and gas completion-fluid formulation, and water treatment. Its supplier base is more fragmented, with Indian and Chinese producers applying cost pressure to established Western suppliers. Other delivery forms include encapsulated and stabilized HBr, which are gaining limited use where handling requirements make bulk anhydrous storage less suitable. These alternatives carry higher per-unit costs and remain in small quantities. The hydrogen bromide market continues to rely on anhydrous material in applications requiring advanced semiconductor process control.

Complete Report Scope:

  • By Product Form
    • Anhydrous Hydrogen Bromide
    • Aqueous Hydrogen Bromide
    • Others
  • By Application
    • Semiconductor Etching
    • Pharmaceuticals
    • Agrochemicals
    • Chemical Synthesis and Catalysis
    • Oil and Gas
    • Others
  • By Geography
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • ASEAN Countries
      • Rest of Asia-Pacific
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • NORDIC Countries
      • Rest of Europe
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Middle East and Africa
      • Saudi Arabia
      • South Africa
      • Rest of Middle East and Africa

Geography Analysis

Asia-Pacific held 41.73% of the hydrogen bromide market share in 2026 and is projected to grow at a 6.54% CAGR through 2032. The region combines advanced logic manufacturing, memory production, and major pharmaceutical API capacity. Taiwan, South Korea, Japan, and China have a high concentration of advanced fabs, while India supports industrial-grade demand through its pharmaceutical manufacturing base. China's self-sufficiency in high-purity liquid HBr increased from below 40% to 65% between 2020 and 2025. However, China still relies on imports from Japan and Taiwan for 5N and 6N grades used in the most advanced nodes.

Planned 12-inch fab expansions in China support predictable demand for HBr. Japan remains an important center for purification, thanks to the specialty-gas capabilities of Resonac and ADEKA. India's Semiconductor Mission is attracting packaging and fabrication investments that could support semiconductor-grade demand later in the forecast period. The hydrogen bromide market in the region, therefore, combines established chip production with newer domestic supply initiatives.

North America held the second-largest geographic position in 2025. CHIPS Act-related fab construction is increasing the need for local high-purity gas supply, including at SK Hynix's Indiana project. Air Liquide's USD 170 million project in Indiana illustrates the co-located infrastructure required by these customers. Europe relies on pharmaceutical synthesis and specialty chemical catalysis, while the EU Chips Act may support semiconductor demand over a longer horizon. South America is driven by demand from Brazil's deepwater pre-salt oil and gas activity, while the Middle East and Africa remain important for bromine feedstock from Dead Sea brines. This geographic pattern leaves the hydrogen bromide market dependent on demand for Asian technology and on geographically concentrated upstream bromine resources.


List of Companies Covered in this Report:

  • ADEKA CORPORATION
  • Air Liquide
  • Albemarle Corporation
  • Bhavika Chemicals Corporation
  • ICL
  • Jordan Bromine Company
  • LANXESS
  • Linde PLC
  • Merck KGaA
  • Neogen Chemicals Limited
  • Nippon Sanso Holdings Corporation
  • Peric Special Gases Co., Ltd.
  • Resonac Holdings Corporation
  • Taihe Gas
  • Tosoh Corporation
  • Triveni Interchem Private Limited

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 Introduction
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 Research Methodology3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Semiconductor Advanced-Node Etch Demand
4.2.2 Pharmaceutical API and Salt-Formation Demand
4.2.3 High-Purity HBr Demand from Fab Localization
4.2.4 Hydrogen-Bromine Flow-Battery Pilots
4.2.5 Precision Etch Requirements in 3D NAND and DRAM
4.3 Market Restraints
4.3.1 Hazardous-Handling and Compliance Costs
4.3.2 Substitution by Alternative Etch Chemistries
4.3.3 Moisture-Induced Gas-System Corrosion
4.4 Value Chain Analysis
4.5 Porter’s Five Forces Analysis
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Power of Buyers
4.5.3 Threat of New Entrants
4.5.4 Threat of Substitutes
4.5.5 Intensity of Competitive Rivalry
4.6 Regulatory Landscape
4.7 Technological Outlook
5 Market Size and Growth Forecasts (Value)
5.1 By Product Form
5.1.1 Anhydrous Hydrogen Bromide
5.1.2 Aqueous Hydrogen Bromide
5.1.3 Others
5.2 By Application
5.2.1 Semiconductor Etching
5.2.2 Pharmaceuticals
5.2.3 Agrochemicals
5.2.4 Chemical Synthesis and Catalysis
5.2.5 Oil and Gas
5.2.6 Others
5.3 By Geography
5.3.1 Asia-Pacific
5.3.1.1 China
5.3.1.2 India
5.3.1.3 Japan
5.3.1.4 South Korea
5.3.1.5 ASEAN Countries
5.3.1.6 Rest of Asia-Pacific
5.3.2 North America
5.3.2.1 United States
5.3.2.2 Canada
5.3.2.3 Mexico
5.3.3 Europe
5.3.3.1 Germany
5.3.3.2 United Kingdom
5.3.3.3 France
5.3.3.4 Italy
5.3.3.5 NORDIC Countries
5.3.3.6 Rest of Europe
5.3.4 South America
5.3.4.1 Brazil
5.3.4.2 Argentina
5.3.4.3 Rest of South America
5.3.5 Middle East and Africa
5.3.5.1 Saudi Arabia
5.3.5.2 South Africa
5.3.5.3 Rest of Middle East and Africa
6 Competitive Landscape
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share (%)/Ranking Analysis
6.4 Company Profiles (includes Global Overview, Market Overview, Core Segments, Financials as available, Strategic Information, Products and Services, and Recent Developments)
6.4.1 ADEKA CORPORATION
6.4.2 Air Liquide
6.4.3 Albemarle Corporation
6.4.4 Bhavika Chemicals Corporation
6.4.5 ICL
6.4.6 Jordan Bromine Company
6.4.7 LANXESS
6.4.8 Linde PLC
6.4.9 Merck KGaA
6.4.10 Neogen Chemicals Limited
6.4.11 Nippon Sanso Holdings Corporation
6.4.12 Peric Special Gases Co., Ltd.
6.4.13 Resonac Holdings Corporation
6.4.14 Taihe Gas
6.4.15 Tosoh Corporation
6.4.16 Triveni Interchem Private Limited
7 Market Opportunities and Future Outlook
7.1 White-Space and Unmet-Need Assessment

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ADEKA CORPORATION
  • Air Liquide
  • Albemarle Corporation
  • Bhavika Chemicals Corporation
  • ICL
  • Jordan Bromine Company
  • LANXESS
  • Linde PLC
  • Merck KGaA
  • Neogen Chemicals Limited
  • Nippon Sanso Holdings Corporation
  • Peric Special Gases Co., Ltd.
  • Resonac Holdings Corporation
  • Taihe Gas
  • Tosoh Corporation
  • Triveni Interchem Private Limited